Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

Title
Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
Authors
Keywords
-
Journal
OPHTHALMOLOGY
Volume 116, Issue 1, Pages 57-65.e5
Publisher
Elsevier BV
Online
2008-12-31
DOI
10.1016/j.ophtha.2008.10.018

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now